Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Earnings, metal rally spur European stocks to record high

Thu, 15th Apr 2021 09:40

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* FTSE 100 hits highest since Feb 2020 as miners jump

* German real estate firms rise as rent cap rule overturned

* Deliveroo slips despite reporting jump in orders

* STOXX 600 Q1 earnings expected to jump over 50% - data
(Updates to close)

By Sruthi Shankar

April 15 (Reuters) - European stocks closed at a record high
on Thursday as a rally in commodity prices lifted mining stocks
and a slate of upbeat earnings reports offset worries about the
pace of COVID-19 vaccinations.

The pan-European STOXX 600 index rose 0.5% in its
third session of gains, with miners jumping 1.5%.

Travel & leisure stocks closed up 0.1% after hitting
a record high earlier in the session.

The UK's commodity-heavy FTSE 100 rose 0.6% to its
highest level since February 2020 as a surge in metals prices
lifted shares of companies such as Rio Tinto, Anglo
American and BHP.

While European stocks have now recovered all of their
pandemic-induced losses from last year, they have lagged their
U.S. counterparts due to a choppy COVID-19 vaccine roll-out as
well as a new wave of infections across the continent.

U.S. drugmaker Johnson & Johnson this week delayed
the roll-out of its COVID-19 shot in Europe, while Denmark said
it would drop a similar vaccine from AstraZeneca over
the risk of blood clotting.

"The euro zone economy might lag others more than we had
expected previously because of the concerns around AstraZeneca,"
said Paul Jackson, global head of asset allocation research at
Invesco.

"Notwithstanding that, once they are vaccinated, European
countries have more to gain than most others."

With U.S. economic data and corporate earnings reports
reinforcing expectations of a swift global economic rebound,
attention this month will turn to the quarterly earnings season
in Europe.

Analysts expect earnings at STOXX 600 firms to rebound more
than 50% in the first quarter following a slide of nearly 40% in
the same quarter a year earlier, according to Refinitiv I/B/E/S
data.

On Thursday, Swiss engineering company ABB rose
3.1% after raising its full-year sales outlook, while French
advertising group Publicis gained 3.3% as it returned
to organic growth for the first time since before the pandemic.

Shares in Publicis' British rival WPP rose 0.5%.

German real estate companies Deutsche Wohnen, LEG
Immobilien and TAG Immobilien rose between
0.9% and 2.5% after the Constitutional Court ruled that a law
putting a rent cap on apartments in Berlin was invalid.

Britain's food delivery company Deliveroo slipped
3.8% even as its quarterly orders more than doubled in its first
trading update since its underwhelming market debut last month.

Norwegian lender Sbanken soared 30.3% after the
country's largest bank DNB agreed to buy the smaller
competitor in a deal worth 11.1 billion Norwegian crowns ($1.3
billion).
(Reporting by Sruthi Shankar in Bengaluru, additional reporting
by Sagarika Jaisinghani, editing by Shounak Dasgupta, Kirsten
Donovan)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.